the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Number of people registered for Covid-19 vaccine in Labuan increases to 44 percent

LABUAN: The number of people registered for COVID-19 vaccine in Labuan has surged from over 16 per cent in March to 44.1 per cent in April.

Labuan COVID-19 Immunisation Task Force (CITF) chairman Rithuan Ismail (pix) said the number of vaccinated individuals here, as of Wednesday, stood at 3,762 including 2,340 frontliners who had completed the second dose end of March.

He said since the launched of phase two of the National COVID-19 Immunisation Programme on Monday, a total of 1, 422 senior citizens aged 60 and above and vulnerable people with morbidity problems have received their first dose.

“This week’s phase two vaccination exercise might not involve persons with disabilities (PwD), as we want to complete the senior citizens first before calling for the PwD’s group probably end of this month or early May,” he told Bernama here today.

Rithuan said Labuan has opened two vaccination centres at Membedai Health Clinic and Labuan Corporation Multipurpose Hall for the phase two vaccination exercise.

Meanwhile, Labuan Health Department director Dr Ismuni Bohari said more than 1,000 teachers have so far registered to get vaccinated.

Dr Ismuni said the department personnel has come up with a vaccination campaign poster on methods for the vaccine registration, namely via MySejahtera, www.vaksincovid.gov.my website, contact vaccine hotline centre at 1-800-888-28 or COVID-19 operation room at 087-596022/029.

Registration can also be done through the people’s representative council (MPP) or via QR Code at http://apps.jknlabuan.moh.gov.my/vaksin. –Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings